Search results
Results From The WOW.Com Content Network
PLINK/SEQ is an open-source C/C++ library designed for analyzing large scale whole-genome and whole-exome studies. MQFAM is a multivariate test of association (MQFAM) that can be efficiently applied to large population-based samples and is implemented in PLINK.
The project makes all sequence data publicly available through GenBank, an international, NIH-funded, searchable online database.This research helps to provide international researchers with the information needed to develop new vaccines, therapies and diagnostics, as well as improve understanding of the overall molecular evolution of Influenza and other genetic factors that determine their ...
Further analysis of HA has shown it to have a very small effective population size relative to the census size of the virus population, as expected for a gene undergoing strong positive selection. [44] However, across the influenza genome, there is surprisingly little variation in effective population size; all genes are nearly equally low. [45]
Population genomics is the large-scale comparison of DNA sequences of populations. Population genomics is a neologism that is associated with population genetics. Population genomics studies genome-wide effects to improve our understanding of microevolution so that we may learn the phylogenetic history and demography of a population. [1]
Influenza B virus is almost exclusively a human pathogen, and is less common than influenza A. The only other animal known to be susceptible to influenza B infection is the seal. [47] This type of influenza mutates at a rate 2–3 times lower than type A [48] and consequently is less genetically diverse, with only one influenza B serotype. [26]
GISAID (/ ˈ ɡ ɪ s eɪ d /), the Global Initiative on Sharing All Influenza Data, [9] previously the Global Initiative on Sharing Avian Influenza Data, [10] [11] is a global science initiative established in 2008 to provide access to genomic data of influenza viruses.
On Thursday, Roche Holdings AG (OTC:RHHBY) released positive topline results of the phase 3 CENTERSTONE study of Xofluza (baloxavir marboxil), an antiviral that showed a reduction in the ...
The NG50 statistic is the same as N50 except that it is 50% of the known or estimated genome size that must be of the NG50 length or longer. This allows for meaningful comparisons between different assemblies. In the typical case that the assembly size is not more than the genome size, the NG50 statistic will not be more than the N50 statistic.